Search research articles
Contact Us
Filters
Showing results (21-30 of 69) with videos related to
Page
of 7
Sort By:
Cancer Investigation
|
September 22, 2000
Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant
N J Meropol, Y M Rustum, P J Creaven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2001
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel
M L Rothenberg, N J Meropol, E A Poplin, et al.
Hybridoma
|
August 1, 1991
A neutralizing monoclonal antibody binds to an epitope near the amino terminus of murine granulocyte-macrophage colony-stimulating factor
N J Meropol, B L Kreider, V M Lee, et al.
Journal of the National Cancer Institute
|
January 4, 1995
Seizures associated with leucovorin administration in cancer patients
N J Meropol, P J Creaven, N J Petrelli, et al.
Cryobiology
|
December 1, 1996
A pilot study of cryochemotherapy for hepatic metastases from colorectal cancer
M A Rodríguez-Bigas, D Klippenstein, N J Meropol, et al.
Oncology Nursing Forum
|
August 24, 2001
Nurses' attitudes toward clinical trials at a comprehensive cancer center
C B Burnett, B Koczwara, L Pixley, et al.
Journal of the American College of Surgeons
|
October 1, 1996
The management of infectious and noninfectious anorectal complications in patients with leukemia
J H North, T K Weber, M A Rodriguez-Bigas, et al.
Cancer Immunology, Immunotherapy : CII
|
October 2, 1998
Evaluation of natural killer cell expansion and activation in vivo with daily subcutaneous low-dose interleukin-2 plus periodic intermediate-dose pulsing
N J Meropol, G M Barresi, T A Fehniger, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
February 10, 1998
Treatment choices by seriously ill patients: the Health Stock Risk Adjustment model
D J Gaskin, J Kong, N J Meropol, et al.
American Journal of Clinical Oncology
|
December 1, 1996
Phase II study of ZD1694 in patients with advanced gastric cancer
N J Meropol, R Pazdur, M Vincent, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 69) with videos related to
Sort By:
Page
of 7
Cancer Investigation
|
September 22, 2000
Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant
N J Meropol, Y M Rustum, P J Creaven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2001
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel
M L Rothenberg, N J Meropol, E A Poplin, et al.
Hybridoma
|
August 1, 1991
A neutralizing monoclonal antibody binds to an epitope near the amino terminus of murine granulocyte-macrophage colony-stimulating factor
N J Meropol, B L Kreider, V M Lee, et al.
Journal of the National Cancer Institute
|
January 4, 1995
Seizures associated with leucovorin administration in cancer patients
N J Meropol, P J Creaven, N J Petrelli, et al.
Cryobiology
|
December 1, 1996
A pilot study of cryochemotherapy for hepatic metastases from colorectal cancer
M A Rodríguez-Bigas, D Klippenstein, N J Meropol, et al.
Oncology Nursing Forum
|
August 24, 2001
Nurses' attitudes toward clinical trials at a comprehensive cancer center
C B Burnett, B Koczwara, L Pixley, et al.
Journal of the American College of Surgeons
|
October 1, 1996
The management of infectious and noninfectious anorectal complications in patients with leukemia
J H North, T K Weber, M A Rodriguez-Bigas, et al.
Cancer Immunology, Immunotherapy : CII
|
October 2, 1998
Evaluation of natural killer cell expansion and activation in vivo with daily subcutaneous low-dose interleukin-2 plus periodic intermediate-dose pulsing
N J Meropol, G M Barresi, T A Fehniger, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
February 10, 1998
Treatment choices by seriously ill patients: the Health Stock Risk Adjustment model
D J Gaskin, J Kong, N J Meropol, et al.
American Journal of Clinical Oncology
|
December 1, 1996
Phase II study of ZD1694 in patients with advanced gastric cancer
N J Meropol, R Pazdur, M Vincent, et al.
Page
of 7